drugset / Trial / NCT00604864

Effect of Anti TNFa Upon Deep Endometriosis Associated Pain

NCT00604864

Phase 2 Completed 20 enrolled KU Leuven
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Deep endometriosis associated pain is believed to be caused by inflammation. Anti TNFa has been proved to be an effective treatment for other inflammation related conditions as Crohn's disease Endometriosis is associated with an inflammatory response in the pelvis, which is mediated by a number of cytokines including TNF-α. It has therefore been suggested that infliximab, an anti-TNF-α monoclonal antibody, might relieve pain in affected women.

Timeline

Start
2004-02
Primary completion
2005-02
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Infliximab Monoclonal antibody 5 mg/kg Intravenous

Indications